What is the proper dosing protocol for vasopressin (Vasopressin) in patients with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vasopressin Dosing Orders for Hypotension

For vasodilatory shock, order vasopressin as a continuous IV infusion at 0.01-0.04 units/minute (NOT units/kg/min), diluted to 0.1 units/mL or 1 unit/mL concentration, administered via central line when possible, and used only as an adjunct to norepinephrine—never as initial monotherapy. 1, 2

Preparation and Dilution

Standard Concentration Options:

  • Option 1: Add 20 units (1 mL of 20 units/mL vial) to 200 mL of normal saline or D5W = 0.1 units/mL 2
  • Option 2: Add 20 units (1 mL of 20 units/mL vial) to 20 mL of normal saline or D5W = 1 unit/mL 2
  • Alternative concentration from guidelines: 25 units in 250 mL of D5W or normal saline = 0.1 units/mL 3

Critical storage requirement: Discard unused diluted solution after 18 hours at room temperature or 24 hours under refrigeration 2

Dosing Protocol by Clinical Scenario

Septic Shock (Most Common Indication)

  • Starting dose: 0.01 units/minute 2
  • Titration range: 0.01-0.07 units/minute 2
  • Maximum dose: 0.04 units/minute (do NOT exceed this in routine practice) 1, 2
  • When to initiate: Add vasopressin when norepinephrine reaches 0.25 mcg/kg/min and hypotension persists (MAP <65 mmHg) 1

Post-Cardiotomy Shock

  • Dose range: 0.03-0.1 units/minute 2
  • This is the ONLY scenario where doses >0.04 units/min are FDA-approved 2

Anaphylaxis (Refractory to Epinephrine)

  • Dose range: 0.01-0.04 units/minute 3
  • Use only when epinephrine and fluid resuscitation have failed 3

Administration Route and Monitoring

Route of Administration:

  • Central venous access is strongly preferred 1
  • Peripheral IV can be used temporarily if central access is unavailable 1

Mandatory Monitoring:

  • Place arterial catheter for continuous blood pressure monitoring 1
  • Monitor ECG continuously 1
  • Check blood pressure and heart rate every 5-15 minutes during initiation 1
  • Assess tissue perfusion markers: lactate clearance, urine output, mental status, capillary refill 1

Critical Pre-Administration Requirements

Before starting vasopressin, you MUST:

  1. Ensure adequate fluid resuscitation: Minimum 30 mL/kg crystalloid bolus 1
  2. Start norepinephrine first: Vasopressin is NEVER first-line monotherapy 1, 2
  3. Verify norepinephrine dose: Should be at least 0.25 mcg/kg/min before adding vasopressin 1
  4. Exclude hypovolemia and cardiac dysfunction: Vasopressin in hypovolemic patients causes severe organ hypoperfusion 1

Sample Order Set

Written Order Example:

Vasopressin 20 units in 200 mL normal saline (0.1 units/mL)
Start at 0.01 units/minute IV via central line
Titrate by 0.01 units/min every 10-15 minutes
Target MAP ≥65 mmHg
Maximum dose: 0.04 units/minute
Monitor: Continuous arterial line BP, ECG, hourly urine output

Titration Strategy

Upward titration:

  • Increase by 0.01 units/min every 10-15 minutes based on MAP response 1
  • Goal: Achieve MAP ≥65 mmHg OR allow reduction of norepinephrine dose 1
  • STOP at 0.04 units/min for septic shock—do NOT exceed this dose 1, 2

Downward titration (weaning):

  • Wean norepinephrine first before reducing vasopressin 1
  • Once norepinephrine is <0.1 mcg/kg/min, begin tapering vasopressin by 0.01 units/min every 30-60 minutes 1

Common Pitfalls to Avoid

Never use vasopressin as first-line therapy: It must be added to norepinephrine, not used alone 1, 2

Never exceed 0.04 units/min in septic shock: Higher doses increase risk of cardiac ischemia, mesenteric ischemia, and digital ischemia without additional benefit 1, 2

Never use vasopressin without adequate volume resuscitation: This causes severe vasoconstriction and organ hypoperfusion 1

Do not confuse units/minute with mcg/kg/min: Vasopressin is dosed in absolute units/minute (NOT weight-based like norepinephrine) 2, 4

Watch for hyponatremia: Vasopressin causes water retention via V2 receptors, leading to dilutional hyponatremia 2

Adverse Effects to Monitor

Cardiovascular:

  • Decreased cardiac output 2
  • Bradycardia 2
  • Tachyarrhythmias 2

Ischemic complications:

  • Coronary ischemia 2
  • Mesenteric ischemia 2
  • Skin/digital ischemia 2

Metabolic:

  • Hyponatremia (most common) 2
  • Reversible diabetes insipidus 2

Drug Interactions

Additive pressor effects: Catecholamines (norepinephrine, epinephrine) have additive effects with vasopressin—this is intentional for combination therapy 2

Indomethacin: May prolong vasopressin effects 2

Ganglionic blockers or drugs causing SIADH: May increase pressor response 2

Drugs causing diabetes insipidus: May decrease pressor response 2

Special Populations

Pregnancy: Vasopressin may induce uterine contractions—use with extreme caution 2

Pediatric patients: Safety and effectiveness have NOT been established in children 2

Geriatric patients: No specific dose adjustments required, but monitor closely for ischemic complications 2

Contraindications

Absolute contraindications:

  • Known allergy to 8-L-arginine vasopressin 2
  • Known allergy to chlorobutanol (preservative) 2

References

Guideline

Vasopressor Management in Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.